CM Life Sciences II Inc.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $200M
- Underwriters
- Focus
- Life Sciences, Healthcare, Biotech
- SEC Filings
- 1837412
- Public Embarc Page
- https://embarc.com/capital/spac/1837412/CMII/cm-life-sciences
- IPO Ticker
- CMII
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive OfficerEli Casdin
- ChairmanKeith Meister(Founder, Corvex Management, Fmr CEO, Icahn Enterprises, Director, MGM, Fmr Director, Yum! Brands, & Motorola)
- Chief Financial Officer and SecretaryBrian Emes
- Chief Strategy OfficerShaun Rodriguez
- Chief Executive Officer and DirectorEli D. Casdin
- ChairmanKeith A. Meister
- DirectorKevin Conroy
- DirectorTroy Cox
- DirectorJason Kelly
- DirectorStephen Quake
Target Information
Information on the SPAC target for merger.
- Company
- SomaLogic
- Presentation
- Investor Presentation (SEC) on 2021-03-29
- Description
- SomaLogic is a commercial stage proteomics company.